Katie Hobbins


This Week in Aesthetics: January 18-22

This week in aesthetics, a study examines tofacitinib to treat alopecia areata, Dr. Michael Kluska compares Renuvion (J-Plasma) versus Bodytite, and more.

ASDS Survey Reports Nearly 14 Million Treatments in 2019

The American Society of Dermatologic Surgery releases its annual survey showing the continued popularity of minimally invasive and nonsurgical treatments.

Tofacitinib for Treatment of Severe Alopecia Areata

A 2017 study examines the long-term efficacy of JAK 1/3 inhibitor, tofacitinib, for treatment of alopecia areata and its variants.

The "Skinimalism" Beauty Trend

This week, consumer magazines highlight the science behind the longevity movement for aging, dermarolling for hair loss, and more.